Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Baxter Healthcare Ltd., Caxton Way, Thetford, Norfolk, IP24 3SE, UK
Metronidazole 500 mg/100 ml Intravenous Infusion.
| Pharmaceutical Form |
|---|
|
Solution for infusion. A clear, almost colourless to pale yellow solution. |
Metronidazole 5 mg/ml.
100 ml of solution for infusion containing 500 mg of Metronidazole.
For excipients see 6.1.
Osmolarity: 308 mOsm/l
pH: 4.5 to 6.0
| Active Ingredient | Description | |
|---|---|---|
| Methronidazole |
Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites. |
| List of Excipients |
|---|
|
Disodium phosphate dodecahydrate |
The bags are composed of polyolefin/polyamide co-extruded plastic (PL 2442) known as Viaflo.
The bags are overwrapped with a protective plastic pouch composed of polyamide/polypropylene, which serves only to provide physical protection to the bags.
The bag size is 100ml.
Outer carton contents: 20 bags of 100ml, 50 bags of 100ml and 60 bags of 100ml.
Baxter Healthcare Ltd., Caxton Way, Thetford, Norfolk, IP24 3SE, UK
PL 00116/0353
12/11/2006
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
